Modus Therapeutics announces FDA Acceptance of Sevuparin IND for treatment of SCD
Modus Therapeutics AB, a company developing innovative treatments in disease areas with high unmet medical need with a focus on sickle cell disease (SCD), announces that the FDA has accepted...
